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A B S T R A C T
Objective: This audit assessed the impact of individualised written recommendations and a computer
message, on repeat prescriptions for calcium and vitamin D supplements, for patients on long term AEDs.
Methods: 1041 adult patients with epilepsy were retrospectively followed from 2004, from the time of
the introduction of the Quality and Outcomes Framework (QOF) and the publication of the National
Institute of Clinical Evidence (NICE) guidelines for epilepsy, up until 2011. In 2009 a clinical notes review
of 414 of the above patients, in Ellesmere Port and Neston (13 practices) was performed, suggesting
supplementation, where appropriate, in a written report. A computer message was added to relevant
prescriptions also recommending supplements, in the above practices plus all 26 practices in Chester and
the surrounding area. The number of patients receiving repeat prescription for supplements in each area
between 2004 and 2011 was analysed.
Results: There was a signiﬁcant increase in the repeat prescriptions of supplements in 2010/11 after the
interventions, the increase being most marked in Ellesmere Port and Neston where both written
recommendations and computer message had occurred compared with the two areas with the computer
message only.
Conclusion: Quality audit with written recommendations, and a message added to the General Practice
(GP) computer systems signiﬁcantly increased the number of repeat prescriptions of calcium and
vitamin D supplements in this group of patients.
Practice Implications: Where clear guidelines are established, this study demonstrates that continuing
education and counselling of GPs and use of computer messaging would result in improved compliance
with such guidelines.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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The risk for skeletal fractures in patients with epilepsy is two to
six times greater than in the general population, either caused by
seizures themselves or by falls, with or without seizures. Side
effects of anti-epileptic drugs (AEDs) such as ataxia or coexisting
neurological deﬁcits may also contribute to the risk for falls.1 The
use of AEDs alone is associated with an increase risk in fractures,
more so in women and those exposed to the AEDs for more than 12
years.2
The older AEDs, which have been studied in depth, have been
consistently shown to have detrimental clinical effects on bone
health, whilst the long-term consequences of treatment with the* Corresponding author. Tel.: +44 8443878396; fax: +44 1244 370762.
E-mail address: ian.minshall@nhs.net (I. Minshall).
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http://dx.doi.org/10.1016/j.seizure.2013.06.002newer AEDs is less well established.3 These effects occur early,
typically in the ﬁrst two years of treatment,4 particularly with
phenytoin.5
Supplementation with calcium and vitamin D is recommended
for all patients receiving long term treatment with benzodiaze-
pines, carbamazepine, phenytoin, phenobarbitol, primidone,
sodium valproate, gabapentin, oxcarbazepine and zonisamide.
Other AEDs such as lamotrigine and levetiracetam appear less
likely to have an adverse effect on bone metabolism.3
The Drug Safety Update (DSU), guidelines from the Drug Safety
Unit, published in April 2009 stated that6:
‘‘The available data suggest that long-term use of carbamaze-
pine, phenytoin, primidone, and sodium valproate is associated
with decreased bone mineral density that may lead to
osteopenia, osteoporosis, and increased fractures in at-risk
patients. Vitamin D supplementation should be considered for
at-risk patients who are taking these medicines long term’’.vier Ltd. All rights reserved.
Table 1
Total number of patients, with changes in number of repeat prescriptions for calcium and vitamin D supplements, from 2004 to 2011 with corresponding year on year
statistical change.
Number of patients 2004/05 2006/07 2008/09 2010/11
Ellesmere Port and Neston (Written recommendation and computer message) 414 22 27 (ns) 32 (ns) 134 (p < 0.0001)
Chester City and Rural practices (Computer message only) 627 22 36 (ns) 52 (ns) 125 (p < 0.0001)
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published in 2004 and updated in 2012, included the following
recommendation7:
‘‘Full blood count, electrolytes, liver enzymes, vitamin D levels,
and other tests of bone metabolism (for example, serum
calcium and alkaline phosphatase) every 2–5 years for adults
taking enzyme-inducing drugs’’.
ScriptswitchTM is a prescription decision support system, which
can be purchased by Primary Care Trusts (PCTs) and added to
General Practice (GP) operating systems. It can be used to add a
recommendation when a drug is prescribed, to direct the
prescriber either clinically or on cost grounds.8
In 2004 the Quality and Outcomes Framework (QOF) for
patients with epilepsy was introduced in the UK. This facilitated
annual review of adult patients with epilepsy in primary care, this
carried a ﬁnancial incentive. The data collected in such a review
was limited to creating a register of patients, recording seizure
frequency, recording patients who were ‘convulsion’ free and a
‘review of AED medication’ in the proceeding 15 months.9 Since the
introduction of QOF the rate of the reviews in the area under study
was on average 95%.10
We postulated that an audit intervention and computer
message would increase the prescription of calcium and vitamin
D supplementation in patients on long term AED therapy.
2. Methods
In 2009 a comprehensive notes review of all patients with
active epilepsy, aged 16 years or older, was undertaken by one of
the authors (IM), a GP with a Special Interest in epilepsy (GPwSIe),
in 13 GP practices in Ellesmere Port and Neston. This included
identiﬁcation of patients prescribed an AED associated with
potential deleterious effect on bone metabolism, with a written
recommendation that appropriate supplementation be prescribed,
in a summary report, to the local GPs. Seventy one percent of these
patients had been prescribed an AED effecting bone for 10 years or
longer. Similar notes reviews had taken place in Chester (13
practices) and the Rural area surrounding Chester (13 practices) in
2002–2004, where no recommendation had been made concerning
calcium and vitamin D supplementation.11,12
At the same time the following message using Scriptswitch
software was added when a prescription was issued: ‘Calcium &
Vitamin D supplementation should be considered for patients
who receive valproate/carbamazepine/phenytoin/primidone for
long-term treatment (DSU Apr 09)’. This occurred in all three
areas.
The GP records of 1041 patients aged 16 or over with a
diagnosis of epilepsy receiving a continual repeat prescription
for an AED were identiﬁed using Graphnet software and
followed from 2004, when the QOF for epilepsy was introduced
for GPs and the NICE epilepsy guidelines were published,
through to 2011. The number of these patients receiving repeat
prescriptions for calcium and vitamin D supplements were also
identiﬁed.
Approval for the study was obtained from the South Cheshire
Local Research Ethics Committee.Categorical variables were analysed using x2 test, using SPSS
13.0 (SPSS Inc., Chicago, IL, USA). A p value of <0.05 was considered
to be statistically signiﬁcant.
3. Results
There were small numbers of supplement prescriptions from
2004 to 2009 with no signiﬁcant year on year change. A
signiﬁcant rise in the number of supplementation prescriptions
occurred in 2010/11 the year after the provision of the written
recommendations and introduction of the computer message
(Table 1).
A statistically signiﬁcant increase in calcium and vitamin D
prescriptions occurred in Ellesmere Port and Neston (written
recommendation and computer message) compared with the City
and Rural (p = 0.0009) practices (computer message alone) in
2010/11, with no difference in the previous period 2008/09.
4. Discussion
This study demonstrates a signiﬁcant increase in the
prescription of calcium and vitamin D supplements following
written recommendations for local GPs, in addition to the
introduction of a computer message. The use of computer
messaging alone resulted in a less marked but still statistically
signiﬁcant increase.
There is evidence that a signiﬁcant proportion of the population
of the UK are vitamin D deﬁcient to begin with.13 The DSU
recommends that vitamin D supplementation should be consid-
ered for patients taking four named AEDs, whilst NICE similarly
recommends the investigation of bone health, although no speciﬁc
recommendation regarding supplementation where appropriate is
made. The literature studying the AEDs and their effect on bone
health suggest a consensus recommending supplementation with
vitamin D and Calcium.3,14 National guidelines with clear
recommendations on investigation of bone health and what to
prescribe, vitamin D with or without calcium, and at what dosage
would be welcome.
Such recommendations would have implications beyond
people with epilepsy on AEDs, as many people on long term AEDs
are on them for indications other than epilepsy (mood stabilisa-
tion, neuropathy and neuralgia).
In the only randomised controlled trial (RCT) for adults on long
term AED therapy patients were prescribed either low dose
(400 IU/day) or high dose (4000 IU/day) vitamin D. Baseline Bone
Mineral Density (BMD) was lower in the adults compared with
controls. After one year BMD scores were signiﬁcantly higher in
those receiving the higher dose, but not in the lower dose group.15
The standard supplementation currently prescribed in the UK
contains 800 IU/day (2 Adcal D3, Calceos etc.) suggesting a higher
formulation is needed. New preparations of vitamin D capsules of
varying strengths have recently become available in the UK, but
were not available at the time of the study.
In this study 71% of patients have been on an AED effecting bone
health for 10 years or more. If this ﬁgure was representative of the
general UK epilepsy population then this would represent a
signiﬁcant health need which is currently not being met.
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all such patients with blood tests and DEXA (Dual Energy X-ray
Absorptiometry) scans and subsequently need to initiate treat-
ment with bisphosphonates, this would have signiﬁcant cost
implications for the NHS budget.
We would recommend, in line with the consensus from NICE
and DSU guidelines, that all people on long-term AEDs effecting
bone (for epilepsy or other indications), have baseline bone
metabolism assessed, and if indicated vitamin D supplements
prescribed. This study has demonstrated that continuing education
and counselling of GPs and the use of computer messaging would
result in better compliance with such guidelines.
We did not identify any potential confounding factors such an
alternative educational programmes in the areas, during the period
under study, to account in the change in prescription practices.
The recommendation regarding supplements and investigation
of bone health could easily be added to the QOF targets for
epilepsy, to remind GPs to consider the prescription of supple-
ments, as the contraception and pre-conception indicators were
added in 2011.
Ideally long term follow up of the identiﬁed cohort in whom the
interventions resulted in supplementation, should be undertaken,
to determine if this results in improved health care (increased BMD
and subsequent reduced fracture rates) compared with people on
long-term AEDs without supplementation.
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